Posted on February 26, 20242/26/24
Q&A: Enhanced Protection and Consistency for PRCI in Canada
Posted on January 30, 20241/30/24
Empowering Success: EVERSANA’s Value & Evidence Team Guides Clients Through CMS Drug Negotiations Under the Inflation Reduction Act
Posted on January 23, 20241/23/24
Redefining Field Deployment – Bridging “Share of Voice” with “Share of Influence” for Lasting Impact
Posted on January 22, 20241/22/24
Uncovering Health Disparities: Exploring Social Determinants of Metastatic Prostate Cancer Survival
Posted on January 19, 20241/19/24
Embarking on the Care Journey: Strategies for Engaging Patients Pre- and Post-Diagnosis
Posted on January 9, 20241/9/24
An Impactful Year for Global Regulation of Digital Health
Posted on January 3, 20241/3/24
Transforming Pharmaceutical Commercialization: Eight Key Insights for Success
Posted on December 21, 202312/21/23
Repairing the Patient Journey: How Pharma Can Fix the Obvious – and Not So Obvious – Breaking Points of Nonadherence
Posted on December 6, 202312/6/23
Linking Channel Distribution & 3PL to Non-Traditional Commercialization Touchpoints
Posted on November 28, 202311/28/23